Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Operating Margin (2020 - 2022)

RAPT Therapeutics' Operating Margin history spans 3 years, with the latest figure at 2134.2% for Q2 2022.

  • For Q2 2022, Operating Margin fell 28368.0% year-over-year to 2134.2%; the TTM value through Mar 2023 reached 10900.68%, down 862886.0%, while the annual FY2022 figure was 5618.53%, 380345.0% down from the prior year.
  • Operating Margin for Q2 2022 was 2134.2% at RAPT Therapeutics, up from 3241.34% in the prior quarter.
  • Across five years, Operating Margin topped out at 954.25% in Q3 2020 and bottomed at 3241.34% in Q1 2022.
  • The 3-year median for Operating Margin is 1622.42% (2021), against an average of 1721.86%.
  • The largest annual shift saw Operating Margin soared 3909bps in 2021 before it crashed -188610bps in 2022.
  • A 3-year view of Operating Margin shows it stood at 1004.99% in 2020, then tumbled by -137bps to 2385.45% in 2021, then grew by 11bps to 2134.2% in 2022.
  • Per Business Quant, the three most recent readings for RAPT's Operating Margin are 2134.2% (Q2 2022), 3241.34% (Q1 2022), and 2385.45% (Q4 2021).